BNVA 150 (Boniva 150 mg)

Generic Name: ibandronate

Pill imprint BNVA 150 has been identified as Boniva 150 mg.

Boniva is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for BNVA 150 (Boniva 150 mg)

Boniva 150 mg BNVA 150 Front
Boniva 150 mg BNVA 150 Back
Boniva 150 mg BNVA 150
Boniva
Generic Name:
ibandronate
Imprint:
BNVA
150
Strength:
150 mg
Color:
White
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-0186
Inactive Ingredients:
lactose monohydrate
povidone k25
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0400 Stat RX USA LLC (repackager)
54868-5322 Physicians Total Care Inc (repackager)
35356-0423 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)